The necessity of extraction of ligand binding data from literature

Simple item page
dc.contributor.authorMarashi, Sayed-Amirde
dc.date.accessioned2008-06-17T14:00:48Z
dc.date.available2008-06-17T14:00:48Z
dc.date.issued2005-10-07de
dc.description.abstractAfter identification and validation of targets in a drug development process, some independent lead compounds should be selected and optimized for their activities. Then, safety assessments and clinical trials decide whether the drug is proper to enter the market. Different stages of this process (and especially the identification of lead compounds) are extremely expensive and time-consuming. Rational drug development methods try to reduce the costs by optimizing the pace of drug discovery and reducing the number of products abandoned during development. For decades, many investigators have studied the ligand-protein interactions, but very few structured databases are devoted to such information. Herein, development of such databases is proposed, since it is obvious that our prior knowledge about the chemico-biological interactions can help us choosing appropriate lead compounds without further experimental and computational investigations, which are usually based on searching in gigantic combinatorial databases of chemical compounds.en
dc.identifier.issn1611-2156de
dc.identifier.urihttp://hdl.handle.net/2003/25656
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-120
dc.language.isoende
dc.relation.ispartofseriesEXCLI Journal ; Vol. 4, 2005en
dc.subjectdrug discoveryen
dc.subjectlead compoundsen
dc.subjectligand bindingen
dc.subjectMining literatureen
dc.subject.ddc610
dc.titleThe necessity of extraction of ligand binding data from literatureen
dc.typeTextde
dc.type.publicationtypearticlede
dcterms.accessRightsopen access
eldorado.dnb.zdberstkatid2132560-1

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Marashi12-05proof.pdf
Size:
42.05 KB
Format:
Adobe Portable Document Format
Description:
DNB
Download

Collections

Review Articles